MUMBAI/February 03, 2026: Galderma India has announced the promotion of Ashish Ghosh as Business Unit Head, Therapeutic Dermatology (TD), furthering the organisation’s continued focus on strengthening leadership depth as the Swiss-based dermatology leader scales its prescription-led offerings in the country.
The Therapeutic Dermatology business represents Galderma’s prescription portfolio and plays a pivotal role in advancing dermatological solutions through Healthcare Practitioners (HCPs).
A homegrown leader, Ashish has spent over a decade with Galderma, beginning his journey in a front-line role and steadily taking on greater responsibility. Over the years, he has gone on to lead the sales and marketing strategy for the Therapeutic Dermatology business, gaining deep on-ground and commercial understanding of the category.
During his tenure, the TD business has consistently delivered blockbuster performance year after year, reinforcing Galderma’s position in the prescription dermatology space. In his new role, Ashish will focus on accelerating growth momentum while strengthening market leadership across the prescription portfolio.
Ashish Ghosh, Business Unit Head, Therapeutic Dermatology, Galderma India said, “Each role across different cities and challenges has helped shape me not just professionally, but personally. At Galderma, the freedom to explore, take ownership and lead from any seat has been a key driver of my development.”
As Galderma continues to expand its presence in India, the company remains focused on investing in internal talent, fostering innovation-led leadership, and driving sustainable, long-term growth across its dermatology portfolio.
Read more: Galderma India Appoints Geetika Saxena As Head Of Digital Strategy
